Xencor, Inc.
Targeting regulatory T cells with heterodimeric proteins
Last updated:
Abstract:
The present invention relates to methods and compositions for modulating T cells. The modulation includes suppressing or inducing regulatory T cells or cytotoxic T cells.
Status:
Grant
Type:
Utility
Filling date:
17 Mar 2014
Issue date:
28 Jan 2020